Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Int J Gynecol Cancer. 2019 Mar;29(3):585-592. doi: 10.1136/ijgc-2018-000154.
There are limited data on clinical outcomes of patients with advanced-stage epithelial ovarian cancer who require ostomy formation at the time of either primary cytoreductive surgery or interval cytoreductive surgery. The objective of this study was to evaluate patients undergoing bowel surgery and ostomy formation after primary or interval surgery.
Patients with International Federation of Gynecology and Obstetrics (FIGO) stage IIIC-IV epithelial ovarian cancer who underwent cytoreductive surgery between January 2010 and December 2014 were identified retrospectively. Patients with non-epithelial histology, low-grade serous histology or incomplete medical records were excluded. Demographic and clinical data were collected and analyzed. Age, stage, co-morbidity index, pre-operative CA125, pre-operative albumin, and Aletti surgical complexity score were included in a multivariable logistic regression model to assess independent associations with ostomy formation.
A total of 554 patients were included in the study. Of these, 261 (47%) underwent primary cytoreduction and 293 (53%) underwent interval cytoreduction. Patients undergoing primary surgery were more likely to undergo bowel resection, compared with interval surgery patients (37.2% vs 14%, p<0.001). Of the 139 (25.1%) patients who underwent bowel surgery, 25 (18%) underwent ostomy formation (11 ileostomies and 14 colostomies). Rates of ostomy formation were similar between the groups (6.1% primary vs 3.1% interval, p=0.10). Patients undergoing ostomy formation were more likely to have longer mean operative time (335 vs 229 min, p<0.001) and undergo small and large bowel resections at the time of cytoreductive surgery (44% vs 14%, p<0.001). Multivariate analysis revealed that a high surgical complexity score was associated with ostomy formation. Of the patients who underwent ostomy formation, 13 (43.3%) underwent stoma reversal including 11 ileostomies and two colostomies. Median time to ostomy reversal was 7 months.
Bowel surgery is more common among patients undergoing primary surgery as compared with interval surgery, but this does not result in an increased risk of ostomy formation.
在初次细胞减灭术或间隔细胞减灭术中需要造口术的晚期上皮性卵巢癌患者的临床结局数据有限。本研究的目的是评估初次或间隔手术后行肠造口术的患者。
回顾性分析 2010 年 1 月至 2014 年 12 月期间接受细胞减灭术的国际妇产科联盟(FIGO)分期 IIIC-IV 上皮性卵巢癌患者。排除非上皮组织学、低级别浆液性组织学或病历不完整的患者。收集并分析人口统计学和临床数据。年龄、分期、合并症指数、术前 CA125、术前白蛋白和 Aletti 手术复杂程度评分纳入多变量逻辑回归模型,以评估与造口术形成的独立相关性。
共纳入 554 例患者,其中 261 例(47%)行初次细胞减灭术,293 例(53%)行间隔细胞减灭术。与间隔手术患者相比,初次手术患者更可能行肠切除术(37.2%比 14%,p<0.001)。在 139 例(25.1%)行肠切除术的患者中,25 例(18%)行造口术(11 例肠造口术和 14 例结肠造口术)。两组造口术形成率相似(初次手术 6.1%,间隔手术 3.1%,p=0.10)。行造口术的患者手术时间较长(335 分钟比 229 分钟,p<0.001),初次细胞减灭术中更可能行小肠和大肠切除术(44%比 14%,p<0.001)。多变量分析显示手术复杂程度评分高与造口术形成相关。在行造口术的患者中,13 例(43.3%)行造口还纳术,包括 11 例肠造口还纳术和 2 例结肠造口还纳术。中位造口还纳时间为 7 个月。
与间隔手术相比,初次手术中更常行肠造口术,但这并不增加造口术形成的风险。